Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

3.

Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.

Pechous R, Celli J, Penoske R, Hayes SF, Frank DW, Zahrt TC.

Infect Immun. 2006 Aug;74(8):4452-61.

4.

Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.

Straskova A, Cerveny L, Spidlova P, Dankova V, Belcic D, Santic M, Stulik J.

Microbes Infect. 2012 Feb;14(2):177-87. doi: 10.1016/j.micinf.2011.08.017. Epub 2011 Sep 8.

PMID:
21930232
5.

Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.

Hickey AJ, Hazlett KR, Kirimanjeswara GS, Metzger DW.

Vaccine. 2011 Sep 16;29(40):6941-7. doi: 10.1016/j.vaccine.2011.07.075. Epub 2011 Jul 29.

6.

Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis.

Kaur R, Chen S, Arévalo MT, Xu Q, Chen Y, Zeng M.

Clin Vaccine Immunol. 2012 Mar;19(3):359-64. doi: 10.1128/CVI.05384-11. Epub 2012 Jan 25.

7.

A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.

Twine S, Byström M, Chen W, Forsman M, Golovliov I, Johansson A, Kelly J, Lindgren H, Svensson K, Zingmark C, Conlan W, Sjöstedt A.

Infect Immun. 2005 Dec;73(12):8345-52.

8.

An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.

Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, Palmer LE, Furie MB, Singh R, Melendez JA, Sellati TJ, Metzger DW.

Vaccine. 2008 Sep 26;26(41):5276-88. doi: 10.1016/j.vaccine.2008.07.051. Epub 2008 Aug 8.

9.

A conserved and immunodominant lipoprotein of Francisella tularensis is proinflammatory but not essential for virulence.

Forestal CA, Gil H, Monfett M, Noah CE, Platz GJ, Thanassi DG, Benach JL, Furie MB.

Microb Pathog. 2008 Jun;44(6):512-23. doi: 10.1016/j.micpath.2008.01.003. Epub 2008 Jan 17.

10.

Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis.

Jia Q, Lee BY, Clemens DL, Bowen RA, Horwitz MA.

Vaccine. 2009 Feb 18;27(8):1216-29. doi: 10.1016/j.vaccine.2008.12.014. Epub 2009 Jan 4.

11.

Francisella tularensis Catalase Restricts Immune Function by Impairing TRPM2 Channel Activity.

Shakerley NL, Chandrasekaran A, Trebak M, Miller BA, Melendez JA.

J Biol Chem. 2016 Feb 19;291(8):3871-81. doi: 10.1074/jbc.M115.706879. Epub 2015 Dec 17.

12.

Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.

Conlan JW, Shen H, Golovliov I, Zingmark C, Oyston PC, Chen W, House RV, Sjöstedt A.

Vaccine. 2010 Feb 17;28(7):1824-31. doi: 10.1016/j.vaccine.2009.12.001. Epub 2009 Dec 16.

14.

Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain.

Sanapala S, Yu JJ, Murthy AK, Li W, Guentzel MN, Chambers JP, Klose KE, Arulanandam BP.

Infect Immun. 2012 Jun;80(6):2177-85. doi: 10.1128/IAI.00036-12. Epub 2012 Apr 9.

15.

Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.

Sebastian S, Pinkham JT, Lynch JG, Ross RA, Reinap B, Blalock LT, Conlan JW, Kasper DL.

Vaccine. 2009 Jan 22;27(4):597-605. doi: 10.1016/j.vaccine.2008.10.079. Epub 2008 Nov 18.

17.
18.

Identification, cloning, expression, and purification of Francisella lpp3: an immunogenic lipoprotein.

Parra MC, Shaffer SA, Hajjar AM, Gallis BM, Hager A, Goodlett DR, Guina T, Miller S, Collins CM.

Microbiol Res. 2010 Sep 20;165(7):531-45. doi: 10.1016/j.micres.2009.11.004. Epub 2009 Dec 14.

19.

Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.

Cowley SC, Meierovics AI, Frelinger JA, Iwakura Y, Elkins KL.

J Immunol. 2010 May 15;184(10):5791-801. doi: 10.4049/jimmunol.1000362. Epub 2010 Apr 14.

20.

A Francisella tularensis SCHU S4 mutant deficient in γ-glutamyltransferase activity induces protective immunity: characterization of an attenuated vaccine candidate.

Ireland PM, LeButt H, Thomas RM, Oyston PC.

Microbiology. 2011 Nov;157(Pt 11):3172-9. doi: 10.1099/mic.0.052902-0. Epub 2011 Aug 18.

PMID:
21852349

Supplemental Content

Support Center